Johnson & Johnson (NYSE:JNJ) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 26, Johnson & ...
MedPage Today on MSN
Assisted Reproduction Linked to Child's Risk of Asthma, Eczema
Children conceived through assisted reproductive technology (ART) were modestly more likely to develop asthma, allergic ...
Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate ...
Small New Year's resolutions could make a big difference in the severity of people allergies and asthma, according to an ...
In 2025, the most-read Healio story on skin disorders was about the impact dietary diversity during pregnancy has on the risk ...
Vietnam Investment Review on MSN
Eczema causes festive isolation for some Singaporeans during gatherings
Skin condition flare-ups during the humid season are leading some individuals to avoid social events and celebrations.
Johnson & Johnson has discontinued a phase 2 trial of one of its pipeline candidates for atopic dermatitis (AD), after it ...
A Pennsylvania mom says she didn’t realize she’d filmed her toddler’s allergic reaction until later — and the TikTok clip ...
Onlymyhealth on MSN
Winter Allergies: 7 Signs You Shouldn’t Ignore During the Cold Months
Sneezing blocked nose itchy eyes this winter It may not be a cold! Read ahead to know the hidden signs of winter allergies ...
Equip health professionals with resources to diagnose and treat conditions across all skin tones. Make mental health support ...
Take steps to reduce stress and anxiety: Meditation, deep-breathing exercises and leisure activities you enjoy will help ...
Stocktwits on MSN
Johnson & Johnson terminates experimental eczema drug study after it fails to show benefit
The drug JNJ-5939 was being evaluated in the treatment of moderate to severe atopic dermatitis in a mid-stage study. ・JNJ, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results